Century Therapeutics Inc (IPSC) stock news · $47.8M cap
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
This IPSC news page leads with what Century Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for IPSC yet. We will not pad this page with generic market recap.
Latest reported IPSC revenue for 2025-09-30 was $109.2M. Net income was $9.6M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. IPSC currently screens at market cap $47.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IPSC stock page; for the tape open the quote page.
IPSC stock news FAQ
What are IPSC's latest revenue and net income?
Latest cached Century Therapeutics Inc (IPSC) revenue for Sep 30, 2025 was $109.2M. Net income was $9.6M. Statements: https://lician.com/financials/ipsc
How did IPSC revenue change from the prior cached period?
Cached Century Therapeutics Inc (IPSC) revenue was unchanged from $109.2M (Jun 30, 2025) to $109.2M (Sep 30, 2025). Statements: https://lician.com/financials/ipsc
What is IPSC's market cap?
Century Therapeutics Inc (IPSC) market cap is $47.8M on the latest cached fundamentals snapshot.
What kind of company is IPSC?
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Where is IPSC stock news listed?
Cached stock news for Century Therapeutics Inc (IPSC) is listed at https://lician.com/news/ipsc. Filings: https://lician.com/sec/ipsc
Not investment advice.